N,2-dimethyl-3-nitroaniline | 848480-17-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N,2-dimethyl-3-nitroaniline
• CAS: 848480-17-1
• 化学式: C8H10N2O2
• 分子量: 166.18
• InChiKey: ACASHMOCWAHWMO-UHFFFAOYSA-N

物化性质

• 沸点：
  282.0±28.0 °C(Predicted)
• 密度：
  1.212±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  57.8
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• [EN] SUBSTITUTED PYRIDYL-CYCLOALKYL-CARBOXYLIC ACIDS, COMPOSITIONS CONTAINING THEM AND MEDICAL USES THEREOF<br/>[FR] ACIDES PYRIDYL-CYCLOALKYL-CARBOXYLIQUES SUBSTITUÉS, COMPOSITIONS LES CONTENANT ET LEURS UTILISATIONS MÉDICALES
  申请人：BAYER PHARMA AG

  公开号：WO2016097013A1

  公开（公告）日：2016-06-23

  The present invention relates to substituted Pyridyl-cycloalkyl- carboxylic acids of general formula (I), to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular in mammals, such as diseases associated with pains, or for the treatment or prophylaxis of pain syndromes (acute and chronic), inflammatory-induced pain, pelvic pain, cancer-associated pain, endometriosis-associated pain as well as endometriosis and adenomyosis as such, cancer as such, and proliferative diseases as such like endometriosis.

  本发明涉及一般式(I)的取代吡啶基-环烷基-羧酸，涉及包括所述化合物的药物组合物和组合物，以及利用所述化合物制造用于治疗或预防疾病的药物组合物，特别是在哺乳动物中，如与疼痛相关的疾病，或用于治疗或预防疼痛综合症（急性和慢性）、炎症诱导的疼痛、盆腔疼痛、癌症相关的疼痛、子宫内膜异位症相关的疼痛以及子宫内膜异位症和子宫腺肌症本身、癌症本身以及增生性疾病本身，如子宫内膜异位症。
• Substituted pyridyl-cycloalkyl-carboxylic acids, compositions containing them and medical uses thereof
  申请人：BAYER PHARMA AKTIENGESELLSCHAFT

  公开号：US10172814B2

  公开（公告）日：2019-01-08

  The present invention relates to substituted Pyridyl-cycloalkyl-carboxylic acids of general formula (I), to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular in mammals, such as diseases associated with pains, or for the treatment or prophylaxis of pain syndromes (acute and chronic), inflammatory-induced pain, pelvic pain, cancer-associated pain, endometriosis-associated pain as well as endometriosis and adenomyosis as such, cancer as such, and proliferative diseases as such like endometriosis.

  本发明涉及通式（I）的取代吡啶基-环烷基-羧酸、包含上述化合物的药物组合物和组合物，以及使用上述化合物制造药物组合物，用于治疗或预防疾病，尤其是哺乳动物的疾病、如与疼痛相关的疾病，或用于治疗或预防疼痛综合征（急性和慢性）、炎症引起的疼痛、盆腔疼痛、癌症相关疼痛、子宫内膜异位症相关疼痛以及子宫内膜异位症和子宫腺肌症、癌症以及子宫内膜异位症等增殖性疾病。
• [EN] HETEROCYCLIC DERIVATIVE, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF<br/>[FR] DÉRIVÉ HÉTÉROCYLIQUE, COMPOSITION PHARMACEUTIQUE ET UTILISATION ASSOCIÉES<br/>[ZH] 一种杂环衍生物、其药物组合物及用途
  申请人：HANGZHOU HUADONG MEDICINE GROUP PHARMACEUTICAL RES INSTITUTE CO LTD

  公开号：WO2021104256A1

  公开（公告）日：2021-06-03

  式I、式II、式III所示的新型杂环衍生物、含有其的药物组合物及在制备预防和/或治疗与质子泵抑制作用调节有关的适应症的药物中的用途。所述杂环衍生物药效强、半衰期长，是理想的高效质子泵抑制剂，可用于治疗或预防需要质子泵抑制作用调节的病症或疾病，例如溃疡、食管炎、胃炎、胃食管反流、幽门螺杆菌感染、胃癌等。
• SUBSTITUTED PYRIDYL-CYCLOALKYL-CARBOXYLIC ACIDS, COMPOSITIONS CONTAINING THEM AND MEDICAL USES THEREOF
  申请人：Bayer Pharma Aktiengesellschaft

  公开号：EP3233802A1

  公开（公告）日：2017-10-25
• SELF-IMMOLATIVE SYSTEMS
  申请人：The Secretary of State for Defence

  公开号：EP3873914A1

  公开（公告）日：2021-09-08